Searched for
GLAXO PHARMA INDIA
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- GSK's Calpol a well-known trademark: High CourtThe Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This desig...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's...
- Focus on 20 key brands to drive growth: GlaxoSmithKline pharmaceuticalsAs part of its growth plans the company is also planning to aggressively expand its field force.
- GSK Pharma to transfer cancer drug portfolio to Novartis armGlaxoSmithKline Pharmaceuticals board approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquirin...
- Novartis shares up nearly 2% at closeShares of Novartis India ended nearly 2% higher after fair trade regulator CCI approved a multi-billion dollar deal between GlaxoSmithKline...
- Underweight on MNC pharma stocks, prefer domestic companies: Pramerica MF"The focus is more on domestic pharma company which have a base in domestic market as well as they have base," Mantri said.
- FIPB clears GlaxoSmithKline's Rs 6,400 cr FDI proposalFIPB today cleared Rs 6,400 crore FDI proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm.
- FIPB to decide on GlaxoSmithKline, other pharma FDI proposalsFIPB will take up tomorrow GlaxoSmithKline's Rs 6,400 crore FDI plan, the largest foreign investment proposal in the pharma sector this fis...
- GSK's open offer for buying stake in Indian arm from February 7-21GlaxoSmithKline Plc's Rs 6,389.02 crore open offer to pick up 24.33 per cent stake in its Indian arm GlaxoSmithKline Pharma will start from...
- Parent offer talk spurs GSK PharmaIt may be the season of open offers by MNCs. GlaxoSmithKline Consumer started it earlier this year, followed by Unilever and, the latest, M...
- GlaxoSmithKline Biologicals in talks to buy BE's vaccine divisionThis division produces and markets a range of paediatric and adult vaccines and has a sizeable market share in the Indian vaccine market.
- 'Glaxo to pay Rs 71.21 cr for not selling drugs at govt price'The High court in August 1981 stayed the drug prices fixed under DPCO and asked the government and Glaxo to go for a settlement.
- India Infoline assigns 'add' to Glaxo SmithklineIndia Infoline has assigned an ‘add’ rating to Glaxo Smithkline Pharma, citing stable growth, zero debt and strong cash balance as the key ...
- Ranbaxy to ink R&D deal with foreign coClose on the heels of striking a strategic alliance with domestic pharma company Orchid, Ranbaxy is close to signing a significant research...
- GlaxoSmithKline Pharma to launch more vaccines in IndiaDrug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
Load More
